New Horizons Forum

The centerpiece of Glaucoma 360, the New Horizons Forum and exhibition convenes key clinical, industry, finance, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment.

Globally, glaucoma is a leading cause of preventable blindness. Glaucoma Research Foundation is presenting the New Horizons Forum in association with Ophthalmology Times to bring together nationally and internationally respected leaders in medicine, science, business, venture capital, and philanthropy -- all intent on transforming new ideas into new hope in the worldwide battle to beat the threat of blindness from glaucoma.

Program

Download the full program booklet (PDF 1.5MB)

The inaugural New Horizons Forum took place on February 3, 2012. A brief summary of the meeting follows. Use the link above to download the program booklet. Be sure to mark your calendar for next year's meeting, taking place on February 1, 2013 at the Palace Hotel in San Francisco!

Presentations by Early-Stage Glaucoma Companies

AcuMEMS, Inc., Aerie Pharmaceuticals, Altheos Inc., Amakem NV, Amorphex Therapeutics LLC, Compact Imaging, Inc., Glaukos, Implandata Ophthalmic Products, iScience, Isis Pharmaceuticals, Inc., NeoMedix, Optovue, pSivida, Transcend Medical, Inc.

Speakers

Wiley A. Chambers, MD
George A. Cioffi, MD
Malvina B. Eydelman, MD
H. Dunbar Hoskins, Jr., MD
James Mazzo
Martin B. Wax, MD

Panel Discussions

• Glaucoma Treatment Devices
• Glaucoma Pharmaceuticals
• Glaucoma Drug and Device Approval Process
• Investing in Glaucoma (Venture Capital)

Schedule

The New Horizons Forum, a full-day program, took place February 3, 2012 at The Palace Hotel in downtown San Francisco.

7:00 AM - Registration

7:30 AM to 5:30 PM - Program

5:30 PM to 7:00 PM - Reception for all participants

New Horizons Exhibit Hall -- open from 7:00 AM to 7:00 PM

Proceeds of the New Horizons Forum benefit the Glaucoma Research Foundation for use in our grant-making and other operational priorities.

Leadership

New Horizons Advisory Board

Sponsors

Alcon, Inc., Allergan, Inc., Santen, Inc.

Abbott Medical Optics, Bausch+Lomb, Canon USA, Lumenis Ltd., OptiMedica, Optovue, Inc., Ora, Versant Ventures, Carl Zeiss Meditec

Accutome, Inc., Aerie Pharmaceuticals, Inc., Alloy Ventures, Altheos, Inc., Amorphex Therapeutics LLC, ELCON Medical, Glaukos Corporation, Heidelberg Engineering, Inc., iCO Therapeutics, IOP Ophthalmics, Iridex, Inc., NeoMedix Corporation, PanOptica, Inc., PPD, Inc., TearLab Corporation, Transcend Medical, Inc.